1. Introduction {#sec1}
===============

The need for an improved vaccine against tuberculosis (TB) has never been more urgent. One in three people today are infected with *Mycobacterium tuberculosis*, the causative agent of TB, and worldwide approximately three million people die from TB annually. The currently available TB vaccine, Bacille Calmette-Guérin (BCG), has failed to consistently protect against the most contagious form of the disease, adult pulmonary TB, despite its widespread use \[[@B1]--[@B4]\]. Developing a new vaccine, which may serve as a booster or a replacement for BCG, is of critical importance in the fight against worldwide TB-related morbidity and mortality \[[@B4], [@B5]\].

Of the various vaccine candidates proposed, fusion subunit vaccines have received considerable attention in the recent literature, especially those composed of antigenic proteins ESAT-6, Ag85B, and TB10.4 \[[@B3]--[@B8]\]. It appears that the multiple epitopes that fusion subunit vaccines offer makes them more effective than single-peptide vaccines in interacting with the complexity of the host immune response against TB and the genetic restriction imposed by major histocompatibility complex molecules \[[@B3], [@B9]\]. Two fusion subunit vaccines, Ag85B-ESAT-6 and Ag85B-TB10.4, which are the focus of the present study, have been found to induce protective cell-mediated immunity in animal models \[[@B3], [@B6], [@B7], [@B9], [@B10]\]. Ag85B-ESAT-6 is currently in expanded Phase I studies in which the vaccine is tested in BCG-vaccinated, latently infected, and individuals from TB endemic regions \[[@B4]\]. As these candidates move forward in or toward clinical trials, it will be critically important to evaluate their protective potential as global vaccines via bioinformatic approaches built upon the comparative genomics of the pathogen population and the immunomics of the host population.

Bioinformatics approaches are invaluable to the development of effective vaccine candidates. Comparative genomics of the pathogen population, for instance, allows vaccine candidates that are potentially ineffective due to genetic diversity of the pathogen population to be discredited before they reach the costly stages of clinical trials. In other words, bioinformatic approaches can provide information based on which a rational selection of clinical trial sites can be made. As for subunit vaccines, comparative genomics can help analyze whether antigenic targets are conserved among infectious strains of an organism in order to ensure their protective efficacy across diverse pathogen populations circulating in different geographic region \[[@B8]\].

Although previous studies have suggested that *M. tuberculosis*has a relatively stable genome in comparison with other bacteria \[[@B11], [@B12]\], recent genomic studies have revealed biologically significant variation among clinical strains \[[@B13]\]. Hebert and colleagues, for instance, revealed considerable genetic variation in the PPE18 gene of *M. tuberculosis*, with important implications for the ability of the Mtb72f vaccine candidate to provoke protective immunity against diverse populations of *M. tuberculosis* \[[@B14]\]. Furthermore, the interaction of the genetic variation of the PPE18 component of Mtb72f with the allelic variation of human MHC-II DRB1 proteins negatively affects vaccine epitope binding to DRB1 proteins \[[@B15]\]. Taken in the context of vaccine development, revelations like these are crucial to the survival of vaccine candidates as potential clinical vaccines. A similar comparative genomics study on Ag85B-ESAT-6 and Ag85B-TB10.4 subunit vaccines may provide useful information for predicting the protective efficacy of these candidates in the pre- or early stages of their clinical evaluation.

Little information has been documented on the genetic variation of the genes encoding for ESAT-6, Ag85B, and TB10.4 proteins. If any of these three genes is highly variable, the protective efficacy of Ag85B-ESAT-6 and Ag85B-TB10.4 subunit vaccines might be compromised on the global stage. To further investigate the ability of these two-vaccine candidates in recognizing naturally occurring *M. tuberculosis*strains, we investigate the genetic diversity of the *esxA*, *esxH*, and *fbpB*genes of *M. tuberculosis* that encode for the components of the two new subunit vaccines in a sample of 88 *M. tuberculosis* strains collected from Turkey and Arkansas, USA.

2. Materials and Methods {#sec2}
========================

2.1. M. tuberculosis Isolates {#sec2.1}
-----------------------------

The clinical strains used in the present study are from Ark, USA, and Turkey. Following the work of Herbert and colleagues, the isolates were selected to represent different geographical regions, including Arkansas and Malatya, Turkey, to assess the impact of regional genetic variability on the two subunit vaccine candidates \[[@B14]\]. Each of the selected isolates represents a different strain of *M. tuberculosis* with a distinct IS*6110* restriction fragment polymorphism (RFLP) pattern with more than five bands or a distinct combination of a common IS*6110* RFLP pattern with five or less bands and a unique spoligo typing pattern ([Table 1](#tab1){ref-type="table"}). The rationale for including isolates from two geographical regions was to discern the potential impact of genetic variation on future vaccination with Ag85B-ESAT-6 and Ag85B-TB10.4 in separate populations.

Our initial intent was to analyze the same set of clinical isolates (*n* = 225) used by Hebert and colleagues in their work on PPE18 and *pepA* \[[@B14]\]. However, after initial sequencing of a randomly selected subset (*n* = 41) of the 225 isolates revealed no genetic variation in the ESAT-6, TB10.4, and Ag85B genes, we selected only 47 of the remaining 84 isolates that had previously shown variation in the PPE18 gene (*n* = 47) for the current study. This decision was made with the consideration of cost-effective lab procedure, reasoning that local genetic variations would be indicative of broader genomic variability. The 88 study isolates represent 57 different strains from Ark, USA, and 31 distinct strains from Turkey. The 88 study isolates shared 49 different spoligotypes that represent 47 different spoligo international types, as determined by using the query tool of the fourth international spoligotyping database (SpolDB4) \[[@B16]\]. The present sample represents 80 of 84 strains (95.2%) that showed PPE18 variation in Hebert\'s study.

2.2. PCR of esxA, esxH, and fbpB Genes {#sec2.2}
--------------------------------------

The three genes under study were amplified using Invitrogen Platinum Taq PCRx Polymerase kit (Invitrogen, Carlsbad, CA) with primers published previously \[[@B17]\]. The primers used for *esxA*, encoding the ESAT-6 protein were esxA-F (5′-GCAATCCGGCGGCTCCACCAG-3′) located 533 bp upstream of the *esxA* gene and esxA-R (5′-TCGGCCGCCATGACAACCTCTC-3′) located 124 bp downstream from the end of the *esxA* gene. The primers used for *esxH*, encoding the TB10.4 protein were esxH-F (5′-GAGAGGGGGAGGCGACGGCTTACC-3′) located 411 bp upstream of the esxH gene, and esxH-R (5′-TCCCCGCCCCAATGGTTTCAGC-3′) located 86 bp downstream from the end of the *esxH* gene. Finally, the primers used for *fbpB*, encoding Ag85B protein were fbpB-F2 (5′-ACTCGGCTAACTGGCTGGTGC-3′) located 217 bp upstream of the *fbpB* gene, and fbpB-R (5′-CATACCGCCATACCGTTTGTGAGC-3′) located 164 bp downstream from the end of the *fpbB* gene. The inclusion of the regions flanking the *esxA*, *esxH*, and *fbpB* genes allowed further confirmation that the PCR products were specific. The positive control in all the PCR reactions was *M. tuberculosis* H37Rv, and the negative control was PCR-grade water. The 50 *μ*L PCR reaction mixture used was composed of 5 *μ*L of 10 × PCRx amplification buffer, 1.5 *μ*L of 50 mM MgSO~4~, 1 *μ*L of 10 mM deoxyribonucleoside triphosphate mixture, 20 pmol of each primer in 1 *μ*L, 0.5 *μ*L of Invitrogen Platinum Taq polymerase mixture, 4 *μ*L of a DNA solution containing 50 ng of DNA template, and 40 *μ*L of PCR-grade water. The thermocycling program used for all genes was one cycle at 94°C for 1 minute; 30 cycles of 94°C for 30 seconds, 62°C for 30 seconds, and 72°C for 2.5 minutes; and a final cycle of 72°C for 10 minutes. The sizes of the PCR products were verified by 1.0% (wt/vol) agarose gel electrophoresis in 1 × Tris-borate-EDTA buffer.

2.3. Automated DNA Sequencing {#sec2.3}
-----------------------------

PCR products were sequenced to identify any insertions/deletions or single nucleotide polymorphisms (SNPs) in the *esxA*, *esxH*, and *fbpB* genes in the selected isolates. PCR products were purified using Invitrogen PureLink PCR Purification Kit, according to manufacturer instructions (Invitrogen, Carlsbad, CA). DNA sequencing was performed with Applied Biosystems DNA sequencers 3700 and 3730 at the University of Michigan Sequencing Core, using the same primers that were used for the PCR of the three genes. The sequences of *esxA*, *esxH*, and *fbpB* of the study strains were compared to those of *M. tuberculosis* laboratory reference strain H37Rv (GenBank accession number [BX842575](http://www.pubmedcentral.nih.gov/redirect3.cgi?&&auth=0PkjJ7aormFMx7CapSp48dSgmzhyVtVGl3JWcjAm-&reftype=extlink-entrez-nucleotide&article-id=2168324&issue-id=158020&journal-id=87&FROM=Article%7CBody&TO=Entrez%7CTerm%7CNucleotide&rendering-type=normal&&http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=nucleotide&dopt=GenBank&list_uids=41353619)) using the BLAST and BLAST2 nucleotide sequence alignment program of the National Center for Biotechnology Information ([http://www.ncbi.nlm.nih.gov/BLAST](http://www.pubmedcentral.nih.gov/redirect3.cgi?&&auth=0LOLPyASjVHQqf7yduecZwOnxmFzKfDW6U3ZaPQRq&reftype=extlink&article-id=2168324&issue-id=158020&journal-id=87&FROM=Article%7CBody&TO=External%7CLink%7CURI&rendering-type=normal&&http://www.ncbi.nlm.nih.gov/BLAST)) and the Sequencher 4.9 DNA Sequence Assembly software (Demo version) of Gene Codes Corporation ([www.genecodes.com](http://www.genecodes.com)). Primary DNA transcripts were translated to amino acid sequences using the *in silico* simulation of molecular biology experiment of the University of Basque Country (<http://insilico.ehu.es/>).

3. Results and Discussion {#sec3}
=========================

3.1. Genetic Diversity of esxA, esxH, and fbpB and Corresponding Amino Acid Sequences {#sec3.1}
-------------------------------------------------------------------------------------

Among the 88 strains investigated, genetic analysis of *esxA*and *esxH*in this study revealed no nucleotide polymorphisms in the genes encoding for ESAT-6 and TB10.4 proteins. Of the 88 strains, 38 (43.2%) belong to principal genetic group 1, 29 (33.0%) belong to principal genetic group 2, and 21 (23.9%) belong to principal genetic group 3. The principle genetic groups were defined by SNPs in the *katG*and *gyrA*genes as described previously by Sreevatsan and colleagues \[[@B12]\]. Unlike the study by Herbert et al., where genetic group 1 strains were found to have the highest frequency of DNA polymorphisms in the PPE18 protein, a component of the Mtb72f vaccine \[[@B14]\], strains in all of the three principal genetic groups showed no DNA variations in both *esxA* and *esxH.*This observation suggests that these gene regions might be conserved among *M. tuberculosis* strains of different geographic origins and among different genetic groups of the pathogen. In fact, Gey Van Pittius and colleagues have recently posited interspecies conservation of the ESAT-6 gene region as part of a novel Gram-positive secretion system with distant homologues in *Bacillus subtilis, Bacillus anthracis, Staphylococcus aureus,*and*Clostridium acetobutylicum* \[[@B18]\].

The analysis of *fbpB,* the gene encoding for Ag85B revealed only one synonymous C to A SNP, located at position 714 bp of the gene sequence, among 39 (44.3%) of the 88 strains sequenced. Double strand sequencing was conducted on the 39 isolates to confirm the existence of this SNP. Although this SNP had no effect on the amino acid sequence of the peptide when translated, it is indicative of an allelic variation in the *M. tuberculosis*gene pool. Of the 39 strains, 15 (17.0%) belong to principal genetic group 1, 11 (12.5%) belong to principal genetic group 2, and 13 (14.7%) belong to principal genetic group 3. Furthermore, the SNP was not found to be associated with any specific geographic origin of the study strains, suggesting that this particular nucleotide polymorphism is of ancestral origin. These data suggest that *M. tuberculosis* Ag85B antigen is highly conserved in, at least, certain populations of *M. tuberculosis*clinical strains.

3.2. Implications for Immunization {#sec3.2}
----------------------------------

TB remains one of the deadliest infectious diseases of our times. Despite widespread use of the BCG vaccine, the disease continues to claim 2-3 million lives per year. The need for a new vaccine has never been more urgent. In order to gain insight into the efficacy of two new vaccine candidates, two fusion proteins combining Ag85B and ESAT-6, and Ag85B and TB10.4 \[[@B6], [@B9], [@B10]\], respectively, the gene regions encoding for ESAT-6, TB10.4, and Ag85B proteins were analyzed for their variability. Experiments involving these two candidates have revealed them to be effective in generating protective immunity in animal models \[[@B6], [@B9], [@B10]\].

Yet, while animal models have played an important role in the development of new TB vaccines so far, they are not always representative of the internal human biological environment. As Flynn noted earlier, an important drawback of the murine model is that the pathology of pulmonary TB in mice is quite different from that in humans \[[@B19]\]. Specifically, the heterogeneity of granuloma types observed in the human host is not displayed in the mouse lung \[[@B19]\]. Similar difficulties arise when using other animal models. In the case of bovine infection, the pathology of TB is quite similar to human host response in granulomatous reactions, but differs with respect to cavitation \[[@B20]\]. Non-human primate models also represent the human pathology of TB quite well, but like cattle are limited by economic and infrastructural factors \[[@B20]\].

Furthermore, current preclinical studies of new TB vaccines\' protection against *M. tuberculosis* infection in animal models do not take the population diversity of *M. tuberculosis* into consideration. However, as Hebert and colleagues noted previously \[[@B14]\], genetic diversity of *M. tuberculosis* genes can be found among clinical isolates, and such diversity may have important implications for the efficacy of the new vaccines. Thus, comparative genomics of the pathogen population stands as an additional useful tool for pre-clinical evaluation of new vaccines, providing information complementary to those from current *in vivo* and *in vitro* studies. Given the resource-demanding nature of clinical trials, comparative genomics serves as a method for predicting the potential protection of proposed vaccines candidates in the general population. Hebert and colleagues\' work revealed that the PPE18 protein, part of the Mtb72f subunit vaccine, was quite variable among isolates collected from Turkey and Arkansas \[[@B14]\]. Analyzing the variability of antigens targeted by potential vaccines in a diverse set of isolates at the genomic level may indeed allow researchers to avoid developing a vaccine that is only variably effective like the current BCG. The findings of such study can also inform the rational selection of the study populations, with a consideration of covering the diverse pathogen populations in clinical trials of new vaccines.

Our observation that ESAT-6, TB10.4, and Ag85B proteins were highly conserved in our study sample comprising strains from two geographically distant regions and three different principal genetic groups suggest that it is unlikely that the efficacy of Ag85B-ESAT-6 and Ag85B-TB10.4 subunit vaccines will be affected by the genetic diversity of *M. tuberculosis* population. Thus, the protective efficacy of these two novel vaccine candidates may have a wider reach than Mtb72b vaccine, which contains a highly variable antigen of *M. tuberculosis* \[[@B14]\]. However, our findings also indicate the need for further bioinformatics research on the three genes investigated and their specific interaction with the host immune system. While highly conserved genes are indicative of homologous protein antigens, they may also suggest a lack of selective pressure by the host immune system and thus a lack of recognition on behalf of the host\'s immune response. Previous examples of the inability of animal models to accurately represent the human host environment suggest that the degree to which the human host system interacts with these important peptides remains to be studied.

The goal of pre-clinical evaluation of these two vaccines may be furthered by future studies that include a larger sample of isolates from a greater range of geographic origins, making the data even more representative of the diversity of *M. tuberculosis*worldwide. The finding of this study that *esxA*, *esxH*, and *fbpB*were conserved across 88 clinical strains from Arkansas and Turkey does not confirm that they are conserved globally. Including a larger and more genetically diverse sample of isolates would address the two primary limitations of this study---the number and diversity of the isolates used.

Another factor that must be taken into account is the potential impact that host diversity may have on the global coverage of these two new TB vaccines. This study looked at the diversity of pathogen genes coding for vaccine proteins, but even uniformly conserved proteins may fail to induce protective immunity if host diversity impedes their ability to effectively bind effector immune cells. McNamara and colleagues provide an eloquent, bioinformatic approach to studying the impact that host diversity may have on Mtb27f vaccine coverage by analyzing the allelic variation of human class II MHC DRB1 proteins and its impact on proper vaccine epitope binding \[[@B15]\]. A similar study on Ag85B-ESAT-6 and Ag85B-TB10.4 may provide insightful information on host diversity and its impact on the coverage of these vaccines.

With these future directions in mind, the results of the present study represent an important first step in the pre-clinical bioinformatic assessment of Ag85B-ESAT-6 and Ag85B-TB10.4 vaccine candidates, and the impact that genetic diversity among their respective antigenic protein targets has on their potential success as global vaccines. The finding that *esxA, esxB,* and *fbpB*genes are highly conserved in two distinct populations suggests that Ag85B-ESAT-6 and Ag85B-TB10.4 vaccine candidates may be effective in geographically distinct areas of the world.
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###### 

Genotyping data of the 88 study isolates of *M. tuberculosis* that were originated from Arkansas, USA, and Turkey.

  Isolate no.\*   IS*6110*Copy no.   IS*6110* RFLP Pattern ¥   Spoligotype          Isolate no.\*   IS*6110*Copy no.   IS*6110* RFLP Pattern ¥   Spoligotype
  --------------- ------------------ ------------------------- ----------------- -- --------------- ------------------ ------------------------- -----------------
  SA143           14                 01046                     000000000003771      SA208           03                 00370                     700036777760471
  SA033           18                 01063                     000000000003771      SA738           07                 05660                     777777744720771
  SA604           18                 04495                     000000000003771      SA204           10                 00636                     074377607760700
  SA327           21                 00237                     000000000003771      SA565           09                 01321                     377737774020731
  SA374           22                 02623                     000000000003771      SA710           17                 02661                     737377677760771
  SA413           22                 02660                     000000000003771      SA221           01                 00129                     774377777413771
  SA193           14                 00638                     677737607760771      SA253           14                 00619                     776377613760771
  SA759           12                 05774                     677777477413771      SA052           03                 00403                     777776777560601
  SA639           15                 04804                     703777740003771      SA333           04                 01658                     777776777560601
  SA085           11                 01336                     776177607760771      SA597           07                 04433                     777776777760761
  SA557           11                 04222                     776177607760771      SA286           08                 01330                     777777000020771
  SA378           09                 02620                     777777770000000      SA198           03                 00370                     777777777613771
  SA652           08                 01646                     777777774020771      SA173           19                 00401                     Not Available
  SA053           11                 00499                     777777774020771      TK035           09                 TK035                     000000004020771
  SA475           05                 04430                     777777777720771      TK036           08                 TK036                     000000007760771
  SA010           09                 00472                     777777777720771      ZD073           15                 ZD073                     703777740003031
  SA637           10                 04802                     777777777720771      TK013           03                 TK013                     777777404760771
  SA213           13                 00640                     777777777720771      TK091           03                 TK091                     777777404760771
  SA364           13                 00807                     777777777720771      TK110           08                 TK110                     777777740460771
  SA025           11                 00325                     777777777760731      ZD039           08                 ZD039                     777777774020771
  SA310           10                 00315                     776177607760771      ZD056           09                 ZD056                     777777774020771
  SA285           06                 01329                     777777777760771      ZD061           08                 ZD061                     777777777720771
  SA169           09                 00326                     777777777760771      ZD063           08                 ZD063                     777777777720771
  SA120           12                 00372                     777777777760771      ZD034           09                 ZD034                     777777777720771
  SA102           12                 00538                     777777777760771      TK086           10                 TK086                     777777777720771
  SA471           14                 06474                     777777777760771      ZD013           10                 ZD013                     777777777720771
  SA131           15                 00627                     777777777760771      ZD020           11                 ZD020                     777777777720771
  SA157           06                 00314                     777777557760771      ZD071           11                 ZD071                     777777777720771
  SA030           13                 00570                     777777607560771      TK065           05                 TK065                     777777777760771
  SA706           10                 05458                     777777777760471      TK103           08                 TK103                     777777777760771
  SA111           02                 00016                     777776777760771      TK095           09                 TK095                     777777777760771
  SA352           03                 00064                     777776777760771      ZD062           09                 ZD062                     777777777760771
  SA019           04                 00432                     777776777760771      TK030           10                 TK030                     777777777760771
  SA170           06                 00327                     777776777760771      TK105           11                 TK105                     777777777760771
  SA341           03                 00694                     777776777760601      ZD093           13                 ZD093                     757777777760771
  SA020           05                 00392                     777776777760601      TK003           06                 TK003                     037637777760771
  SA596           07                 04432                     777776777760601      ZD041           06                 ZD041                     777777764020731
  SA526           01                 00195                     777777776413771      ZD031           09                 ZD031                     717777777760771
  SA162           04                 00319                     700076777760700      ZD024           09                 ZD024                     770000770000000
  SA778           08                 06019                     376177607760771      TK007           08                 TK007                     777767777760671
  SA038           11                 00496                     777777777320771      TK016           07                 TK016                     037227760160771
  SA512           12                 00832                     776377770760771      TK011           08                 TK011                     700377777760771
  SA189           13                 00598                     777763777760771      TK112           09                 TK112                     777207777777661
  SA430           01                 00129                     763777777413771      TK097           05                 TK097                     Not Available

\*Isolate  numbers starting with SA refer to strains from Arkansas, USA. Isolate numbers starting with ZD or TK refer to strains from Turkey.

¥ The IS*6110* RFLP patterns of the Arkansas strains were indicated using the national designations assigned by the National Tuberculosis Genotyping and Sentinel Surveillance Network Program of the Centers for Disease Control and Prevention. The IS*6110* RFLP patterns of the Turkish strains were designated using the isolate number in which a given IS*6110* RFLP pattern was observed for the first time.
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